• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Meta-analysis of the clinical efficacy of Liqi Huoxue drop pill in the treatment of angina pectoris in coronary artery disease

    2022-02-04 10:32:10HANYiHANYuboZOUGuoliangSUIYanboDONGXinyuLIULi
    Journal of Hainan Medical College 2022年21期
    關鍵詞:滴丸理氣胸痹

    HAN Yi, HAN Yu-bo, ZOU Guo-liang, SUI Yan-bo, DONG Xin-yu, LIU Li?

    1. Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China

    2. The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China

    Keywords:

    ABSTRACT

    1. Introduction

    Coronary artery disease is short for coronary heart disease, also known as ischemic heart disease, and is clinically divided into five types, namely asymptomatic, angina pectoris, myocardial infarction,ischemic cardiomyopathy and sudden death, among which the coronary angina pectoris type is more common. The pathological mechanism of coronary angina is atherosclerosis or the formation of plaque in the inner wall of blood vessels, which leads to luminal narrowing or blood rheology changes, resulting in impaired coronary circulation, which in turn affects the blood supply to cardiomyocytes. The main clinical symptoms of coronary angina are chest discomfort or posterior sternal paroxysmal pressure during episodes that affect patients' quality of life, and in severe cases,myocardial infarction or even life-threatening [1]. Coronary angina has been one of the major causes of death in China. The index of suffering from coronary angina in China has increased significantly compared to previous years, mainly due to the dramatic deterioration of the prevalence of coronary angina-causing risk factors such as hypertensive disease, hyperlipidemia, and diabetes[2]. At present, the clinic mainly adopts a comprehensive program of anticoagulation,cardiac strengthening, vasodilatation, and lipid regulation[3], and conventional Western medicine treatment can be effective, but also has certain toxic side effects, while Chinese medicine has little side effects and significant therapeutic effects, which provides a new treatment idea for the clinic.

    Chinese medicine is often used as a supplement and alternative to Western medicine in the treatment of coronary angina, and the combination of Chinese and Western medicine can improve the efficacy of coronary angina treatment, reduce the incidence of coronary angina, and avoid the adverse reactions and side effects of Western medicine treatment. It is a new Chinese medicine developed by China for the treatment of angina pectoris in coronary heart disease, and it is a proprietary Chinese medicine preparation based on Chinese medicine theory and modern preparation technology. It consists of four Chinese herbal medicines, namely, Daguomujiangzi,Bingqi (natural ice chips), Chuanxiong and Allium, which have the effects of broadening the chest and dispersing knots, regulating Qi and activating blood flow [4]. There have been a certain number of RCT trials on the combination of Li qi huo xue dropping pills with western medicine on angina pectoris in coronary heart disease, but evidence from evidence-based medicine is still lacking. The aim of this study was to evaluate the efficacy of combining Li qi huo xue dropping pills with western drugs in the treatment of angina pectoris in coronary heart disease, with the aim of providing evidencebased medical evidence for the clinical application of Li qi huo xue dropping pills in the treatment of angina pectoris in coronary heart disease. Because there are few clinical randomized controlled trials on the combination of Li qi huo xue dropping pills with Western medicine for the treatment of angina pectoris in coronary heart disease, a more convincing subgroup analysis of outcome indicators could not be performed, so only Meta-analysis of relevant indicators was performed.

    2. Materials and Methods

    2.1 Literature search strategy

    Search by computer in Chinese databases (CNKI, VIP, WanFang Data and CBM) with"理氣活血滴丸","心絞痛","冠心病","冠心病心絞痛","胸痹", etc.In English databases (PubMed,Embase, Web of Science, Cochrane Library) with "Lifting qi and activating blood drop pills", "Li qi huo xue dropping pills", and "Coronary heart disease", "CHD", "angina pectoris", "random control trial", etc.The search was conducted using a combination of subject terms and free words. For PubMed, for example, see Box 1 for the specific search strategy.Box 1 PubMed search strategy

    2.2 Inclusion and exclusion criteria

    2.2.1 Study type

    A randomized controlled trial (RCT) of Li qi huo xue drop pill for the treatment of angina pectoris in coronary artery disease, with no restrictions on the publisher's rank or region and restrictions on language to Chinese or English only.

    2.2.2 Research subjectsThe subjects included in the study must be patients diagnosed with coronary angina, and the diagnostic criteria were referred to the relevant diagnostic criteria for coronary angina in Nomenclature and diagnostic criteria of ischemic heart disease [5].

    2.2.3 Interventions

    Control group: conventional Western medical treatment with unlimited types, doses and courses of Western medicine.

    Intervention group: Combined with the Li qi huo xue drop pill on the basis of the control group.

    2.2.4 Ending indicators

    ① clinical efficacy, ②efficacy of angina symptoms, ③number of angina attacks, ④serum inflammatory index interleukin-6 (IL-6),⑤serum interleukin-18 (IL-18), ⑥high-sensitivity C-reactive protein(hs-CRP), ⑦endothelial function index nitric oxide (NO)

    2.2.5 Exclusion criteria

    ①literature in which the type of study was animal experiments or pharmacological studies;②literature in which severe cardiac, hepatic,or renal insufficiency and drug allergy were combined;③literature in which the control and treatment groups included acupuncture,surgery, or other treatment modalities;④literature with obvious data errors;⑤literature with missing data;⑥literature in languages other than Chinese or English;⑦iterature with duplicate publications;⑧l(xiāng)iterature that has not been published.

    2.3 Risk of bias evaluation of included studies

    The included clinical randomized controlled studies were assessed for "risk of bias" using the "risk of bias assessment" tool recommended in the Cochrane 5.1.0 manual. The assessment was based on random sequence generation, allocation concealment,blinding of patients and participants, blinding of outcome assessors,completeness of outcome data, selective reporting, and other biases.Two investigators gave low risk, unclear, or high risk assessments for the included as-randomized controlled trials, and the two cross-checked their respective results after completion. If the two investigators disagreed with the results, they were referred to a third person for risk of bias assessment.

    2.4 Statistical treatment

    Meta-analysis of the included literature data was performed using RevMan 5.4 software provided by the Cochrane Collaboration Network. Measured variables (continuous variables) Weighted mean difference (WMD) was used as a statistic when the same intervention was measured by the same method or unit, otherwise, standard mean difference (SMD) was used as a statistic. The relative riskiness (RR)of the count variable was used as an effect size analysis statistic.Heterogeneity in the included studies was determined using the χ2test (detectionlevela= 0.1). When P≥0.1 and I2≤50%, the heterogeneity of the study data was low and a fixed-effects model should be used; when P < 0.1 and I2> 50%, it indicated that there was significant heterogeneity in the study data and a heterogeneous random-effects model should be used and the source of heterogeneity should be further analyzed. If significant clinical heterogeneity was present, subgroup analysis was performed. If clinical heterogeneity was evident but subgroup analysis could not be performed, Metaanalysis could not be performed and only descriptive analysis could be used. When the number of primary data indicators in the included studies was greater than 10, funnel plots should be used to assess publication bias.

    3. Results

    3.1 Literature screening process and results

    Based on the above search criteria, a total of 87 relevant papers were obtained. The full text was carefully read and screened according to the inclusion and exclusion criteria, and only 9 papers met the inclusion criteria [6-14]. The observation group was treated with the combination of Western medicine using the Li qi huo xue drop pill and included 491 patients. The control group was treated with conventional Western medicine only and included a total of 491 patients. The literature screening process is shown in Figure 1.

    3.2 Quality evaluation results of the included studies

    Regarding the method of random assignment, one study was high risk [8]and randomized by time of visit, hospitalization number,and clinical treatment intention method. seven studies mentioned randomization only and did not specify the random assignment scheme [6,9-14]. one study was low risk [7] and reported specific random grouping methods, including random number table methodassignment. The random assignment scheme was concealed, and aspects of blinding and other sources of bias were unclear, resulting in low risk for both data completeness and selective reporting. The results of the risk of bias assessment for the included studies are shown in Figure 2.

    Tab1 Basic information of literature included

    Fig1 Flowchart of literature screening

    Fig2 Risk of bias of literature included

    3.3 Meta-analysis results

    3.3.1 Clinical efficacyFive clinical randomized controlled trials reporting clinical efficacy were included [6-10], as shown. Each study was homogeneous(P=0.90; I2=0%). Statistical analyses were performed using homogeneity fixed-effects models. The RR and 95% CI for clinical efficacy were RR = 1.20 and 95% CI = [(1.12, 1.29) P<0.000 01];the results showed that the intervention group had better clinical efficacy than the control group, and the difference was statistically significant. (Figure 3)

    Fig3 Forest plot of clinical efficacy of angina in coronary heart disease between intervention and control group

    3.3.2 Efficacy of angina pectoris symptomsThree clinical randomized controlled trials reporting the efficacy of angina symptoms were included [11-13], as shown. Each study was homogeneous (P=0.85; I2=0%). Statistical analyses were performed using a homogeneous fixed effects model. The RR and 95% CI for angina symptom efficacy were RR = 1.17 and 95% CI = [(1.07, 1.29)P = 0.001]; the results showed that the intervention group had better angina symptom efficacy than the control group, and the difference was statistically significant. (Figure 4)

    3.3.3 Number of angina attacks

    The number of angina episodes reported by the 3 clinical randomized controlled trials [8,13,14] was included, as shown. Each study was heterogeneous (P<0.000 01; I2=97%). Statistical analysis was performed using a heterogeneous random-effects model. for the number of angina attacks [SMD= -2.26, 95% CI (-4.10,-0.42),P=0.002]; the results showed that the number of angina attacks was lower in the intervention group than in the control group, and the difference was statistically significant. (Figure 5)

    3.3.4 Serum inflammatory indicator interleukin-6 ( IL-6)

    Four clinical randomized controlled trials reporting interleukin-6 were included [6,9,11], as shown. Each study was heterogeneous(P=0.11; I2=55%). Statistical analysis was performed using a heterogeneous random effects model. The [MD= -4.65, 95% CI(-6.91,-2.39), P<0.000 1] for interleukin-6; the results showed that interleukin-6 was lower in the intervention group than in the control group, and the difference was statistically significant. (Figure 6)

    Fig4 Forest plot of clinical efficacy of angina in coronary heart disease between intervention and control group

    Fig5 Forest plot of angina attacks in coroary heart disease of both groups

    Fig6 Forest plot of IL-6 comparison of angina in coronary heart disease of both groups

    3.3.5 Serum inflammatory indicator interleukin-18 ( IL-18)

    Interleukin-18 reported in 3 clinical randomized controlled trials were included [9,10,12], as shown. Each study was homogeneous(P=0.23; I2=32%). Statistical analysis was performed using a homogeneity fixed-effects model. Interleukin-18 of [MD=-2.53, 95%CI (-2.84,-2.22), P<0.000 01]; the results showed that interleukin-18 was lower in the intervention group than in the control group, and the difference was statistically significant. (Figure 7)

    Fig7 Forest plot of IL-8 comparison of angina in coronary heart disease of both groups

    3.3.6 High-sensitivity C-reactive protein (HS-CRP)

    High-sensitivity C-reactive protein reported in four clinical randomized controlled trials [6,9,11,14] was included, as shown. Each study was heterogeneous (P=0.31; I2=55%). Statistical analysis was performed using a heterogeneous random effects model. The[MD=-0.08, 95% CI (1.81,-0.75), P<0.000 01] for high-sensitivity C-reactive protein; the results showed that the intervention group had lower high-sensitivity C-reactive protein than the control group, and the difference was statistically significant. (Figure 8)

    3.3.7 Endothelial function indicator nitric oxide (NO)

    Three clinical randomized controlled trials reporting on endothelial function indicators of nitric oxide were included[8,11,14], as shown.Each study was heterogeneous (P<0.000 01; I2=96%). Statistical analysis was performed using a heterogeneous random effects model. for the endothelial function index nitric oxide [MD= 8.03,95% CI (0.93,15.14), P=0.03]; the results showed that the endothelial function index nitric oxide was higher in the intervention group than in the control group, and the difference was statistically significant.(Figure 9)

    Fig8 Forest plot of Hs-CRP comparison of angina in coronary heart disease of both groups

    Fig9 Forest plot of NO comparison of angina in coronary heart disease of both groups

    3.3.8 Adverse drug reactionsIn one study, there was one case of headache and dizziness, three cases of gastrointestinal discomfort, and one case of rash in the control group; in the intervention group, there were two cases of headache and dizziness and five cases of gastrointestinal discomfort;in one study, there were two cases of vomiting, three cases of abdominal pain, and two cases of rash in the control group; and in the intervention group, there were two cases of epigastric discomfort and one case of rash. (Table 2)

    Tab2 Adverse reaction events of the drug used

    3.3.9 Sensitivity analysis

    All the outcome indicators included in the study were ranked one by one to find the source of heterogeneity. When sensitivity analysis was performed on the indicator IL-6, it was found that excluding the study of Shi Ming et al [11], heterogeneity was reduced (P<0.000 01, I2=0%), and the results showed that IL-6 was significantly lower in the intervention group than in the control group [MD= -5.82,95% CI (-6.92,-4.71), P<0.000 01]. When sensitivity analysis was performed on the index IL-18, a reduced heterogeneity (P<0.000 01,I2=0%) was found excluding the study of Weng Jiao et al [9], which showed that IL-18 was lower in the intervention group than in the control group [MD= -2.66, 95% CI (-3.01,-2.31), P<0.000 01]. When sensitivity analysis was performed on the index HS-CRP, a reduction in heterogeneity (P<0.000 01, I2=0%) was found excluding the study of Li Yan et al [6], which showed that HS-CRP in the intervention group was lower than in the control group [MD=-1.53, 95% CI(-1.93,-1.14) , P<0.000 01]. When sensitivity analysis was performed on this indicator of NO, it was found that excluding the study of Shi Ming et al [11], heterogeneity was reduced (P<0.000 01, I2= 0%),and the results showed that NO was higher in the intervention group than in the control group [MD=4.23, 95% CI (2.49,5.97), P<0.000 01]. The final results were not significantly different from those before the exclusion of heterogeneous sources. When analyzing the heterogeneity of other indicators, the heterogeneity did not vary significantly and is not listed. The results of the heterogeneity analysis indicate that the results of this study are relatively stable and have reference value.

    3.3.9 Publication bias

    Because of the small number of studies included for individual outcome indicators, this study was not tested for publication bias.

    4. Discussion

    In recent years, the incidence of coronary angina has increased significantly in China. The symptoms of clinical patients during attacks are no longer limited to pain in the anterior region of the heart, but have even seriously affected their psychological status and quality of life. At present, the drugs commonly used clinically for the treatment of coronary angina are mainly western drugs such as nitroglycerin, beta-blockers and calcium channel blockers. However,the long-term use of these western drugs may cause side effects such as gastrointestinal bleeding, slow heart rate or low blood pressure,and the long-term efficacy is not satisfactory. Therefore, there is a great need to find a treatment option for angina pectoris with few side effects and significant efficacy.

    Angina pectoris in coronary artery disease belongs to the category of "chest paralysis" in Chinese medicine. According to Chinese medicine, "chest paralysis" is mainly due to deficiency of qi and blood and blood stasis blocking the heart arteries. The pathogenesis of pain in the anterior region of the heart is due to deficiency of qi,blood, yin and yang in the body, and phlegm, cold, qi stagnation and blood stasis blocking the heart arteries and channels, resulting in"pain when it does not pass". The effect of Li qi huo xue dropping pill is to benefit Qi, warm Yang, activate blood circulation and remove blood stasis, which can effectively reduce the clinical symptoms of patients. The main ingredient of Li qi huo xue dropping pills is Dagongmujiangzi, which was found to have a protective effect on myocardial injury in a rat model of atrial fibrillation and acute myocardial ischemia[15,16]. Ice chips have the effect of opening the body and waking the mind, clearing heat and relieving pain, and based on modern network pharmacological investigation, it was found that there are three targets in ice chips that have important efficacy in the treatment of coronary heart disease, effectively targeting the symptoms and eliminating the disease[17]. Allium sativum has the ability to move qi and channel stagnation, pass yang and disperse nodules, which can eliminate blood stasis and ensure smooth blood circulation. The other main ingredient, Chuanxiong,has the function of activating blood circulation, dispelling wind and relieving pain. Modern research has proved that Chuanxiong has the function of promoting blood circulation, anti-inflammatory, anticoagulation and vasodilation, it can significantly reduce the viscosity of whole blood and plasma, inhibit platelet aggregation, increase coronary blood flow, improve cardiac microcirculation, and reduce plaque formation [18], and Chuanxiong has a protective effect on cardiovascular endothelial cells, which is the one of the best drugs to choose in the treatment of chest paralysis[19]. Combined together,the four drugs promote qi-blood circulation, harmonize qi and blood,and exorcise stasis, ventilate qi, and relieve pain.

    In this paper, through Meta-analysis of nine included studies,the results showed that the intervention group was significantly better than the control group in improving clinical efficacy and the efficacy of angina pectoris symptoms, indicating that Li qi huo xue dropping pill can effectively improve the clinical symptoms of patients with coronary angina pectoris. The increase of highsensitivity C-reactive protein indicates the high level of vascular inflammation, which leads to the instability of arterial plaque,and high-sensitivity C-reactive protein is an effective independent predictor of cardiovascular disease [20]. The changes in endothelial function and coronary angina are closely related to each other [21],and damage to endothelial structure and function is an important cause of atherosclerotic plaque formation and the earliest sign of vascular lesions[22],and have a predictive value for long-term cardiovascular events, which were lower in the intervention group than in the control group, indicating that Li qi huo xue dropping pill can effectively inhibit the inflammatory response of the body to have a protective effect on the myocardium; the results of this study showed that Li qi huo xue dropping pill can improve the clinical efficacy of angina pectoris in coronary heart disease to some extent,and can reduce IL-6, IL-18.The results of the present study showed that Li qi huo xue dropping pills could improve the clinical efficacy of angina pectoris in coronary heart disease to a certain extent, and could reduce IL-6, IL-18, HS-CRP levels and the number of angina attacks, and improve NO levels and the efficacy of angina symptoms,indicating that Li qi huo xue dropping pills has a better therapeutic effect on angina pectoris in coronary heart disease, and can also improve patients' quality of life and delay disease progression. In terms of safety, two studies reported adverse reactions. 8 cases of gastrointestinal discomfort, 1 case of dizziness and 3 cases of skin rash were observed in the control group. In the intervention group,there were 8 cases of gastrointestinal discomfort, 2 cases of dizziness and headache, 7 cases of gastrointestinal discomfort, and 1 case of rash. There were no serious adverse reactions in the intervention group, and the incidence of adverse reactions in the intervention group was lower than that in the control group, suggesting the relatively high safety of the treatment with Li qi huo xue dropping pills.

    In conclusion, the combination of Li qi huo xue dropping pill with conventional western medicine treatment for patients with coronary angina can effectively improve the clinical outcome, the efficacy of angina symptoms, the number of angina attacks, the NO index of endothelial function, and reduce serum inflammatory indexes IL-6,IL-18, and HS-CRP.

    However, the consistency among studies was not high due to the low quality of the literature of the original studies included and the limited number of samples included, the different control measures, and the large variety of drugs included in the conventional treatment in Western medicine. This meta-analysis also has some limitations:①None of the nine studies included in this paper mentioned blinding and allocation concealment, one study used the randomized numerical table method, and the rest did not describe the randomization method, which made the quality of the studies poor;all studies did not describe patient loss or withdrawal, which did not correspond to the clinical reality and the data may be untrue; different drug doses, length of intervention The differences in drug doses,duration of intervention, and measurement of indicators may lead to increased heterogeneity of the studies. Therefore, more multicenter,large sample, double-blind and other high-quality randomized controlled clinical trials are needed for further confirmation to better guide clinical drug use.②The number of studies included in this study was small, and the included studies were published in China,and the populations were all Chinese populations or even small parts of China, and it is unclear whether the findings of this study are also applicable to other regions or other ethnic groups.③Also, due to language ability limitations, our search was limited to Chinese and English literature, and we may have overlooked studies or reports in other languages. Therefore the above study findings still need to be supported by more high-quality clinical randomized controlled trials and high-quality literature to provide a more reliable therapeutic basis for modern clinical practice.

    Author Contribution Description

    (First author)Han Yi:research design, implementation of the study,data collection and statistical analysis, and article writing.

    (Second author)Han Yubo:work supervision, article content review.

    (Third author) Zou Guoliang:work supervision, technical support,etc.

    (Fourth author) Sui Yanbo:work supervision, technical support, etc.

    (Fifth author) Dong Xinyu:collection and statistical data, etc.

    (Corresponding author) Liu Li:research design, work direction,article review, etc.

    Conflict of Interest Statement

    The author declares that the content and opinions expressed in the paper are neutral and objective, and that there is no conflict of interest.

    猜你喜歡
    滴丸理氣胸痹
    理氣舒筋法在人工全膝關節(jié)置換術后加速康復中的應用研究
    張艷治療胸痹臨床經驗
    活血化瘀法論治胸痹
    穿心蓮內酯滴丸
    胸痹氣虛證療效評價量表探討
    對朱子理氣關系論的重新考察
    船山學刊(2017年4期)2017-08-10 18:27:19
    HPLC法測定蒙藥新Ⅰ號滴丸中沒食子酸的含量
    連參滴丸制備工藝的優(yōu)選
    厚樸花滴丸質量標準的研究
    辨證施護胸痹60例
    亚洲三区欧美一区| 免费一级毛片在线播放高清视频 | 国产1区2区3区精品| 国产av一区在线观看免费| 日本 欧美在线| 久久人妻福利社区极品人妻图片| 国产亚洲欧美在线一区二区| 欧美日本中文国产一区发布| 欧美黄色片欧美黄色片| 国产精品免费一区二区三区在线| 欧美在线黄色| 国产又爽黄色视频| 久久亚洲精品不卡| 国产xxxxx性猛交| 久久精品国产亚洲av香蕉五月| 国产午夜精品久久久久久| 人成视频在线观看免费观看| 久久久久精品国产欧美久久久| 女性被躁到高潮视频| 亚洲自拍偷在线| www.999成人在线观看| 麻豆av在线久日| 午夜福利成人在线免费观看| 国产精品1区2区在线观看.| 免费看a级黄色片| 国产精品日韩av在线免费观看 | 欧美+亚洲+日韩+国产| 1024香蕉在线观看| 亚洲人成电影观看| 91老司机精品| 老司机靠b影院| 精品国产美女av久久久久小说| 亚洲精品中文字幕一二三四区| 两人在一起打扑克的视频| 精品高清国产在线一区| 午夜福利18| 亚洲无线在线观看| 女人精品久久久久毛片| 国产亚洲精品av在线| 成人av一区二区三区在线看| 国产免费av片在线观看野外av| 88av欧美| 亚洲五月婷婷丁香| 桃色一区二区三区在线观看| 国产1区2区3区精品| 999久久久国产精品视频| 天堂√8在线中文| 香蕉国产在线看| 国产精品一区二区免费欧美| 国产午夜福利久久久久久| 国产欧美日韩一区二区三| 老鸭窝网址在线观看| 精品日产1卡2卡| 欧美 亚洲 国产 日韩一| 最好的美女福利视频网| 国产高清有码在线观看视频 | 亚洲性夜色夜夜综合| 国产精品秋霞免费鲁丝片| 免费一级毛片在线播放高清视频 | 婷婷丁香在线五月| 国产精品国产高清国产av| 丁香欧美五月| а√天堂www在线а√下载| 久久草成人影院| 日韩国内少妇激情av| 亚洲自拍偷在线| 午夜亚洲福利在线播放| 日韩欧美在线二视频| 国产精品一区二区精品视频观看| 欧美黑人欧美精品刺激| bbb黄色大片| 免费一级毛片在线播放高清视频 | 美女扒开内裤让男人捅视频| 日韩中文字幕欧美一区二区| 一二三四社区在线视频社区8| 波多野结衣一区麻豆| 精品久久久久久久久久免费视频| 天天躁夜夜躁狠狠躁躁| 日本免费a在线| 国产成人欧美在线观看| 亚洲欧美精品综合一区二区三区| 精品人妻在线不人妻| 国产成人精品在线电影| 成在线人永久免费视频| 国产av精品麻豆| 国产成人精品久久二区二区91| 人人妻人人澡人人看| 中文字幕最新亚洲高清| 久久国产亚洲av麻豆专区| 97人妻天天添夜夜摸| 成人精品一区二区免费| 成人18禁在线播放| 两人在一起打扑克的视频| 后天国语完整版免费观看| av视频在线观看入口| 国产成人精品久久二区二区91| 给我免费播放毛片高清在线观看| 一本久久中文字幕| 99久久国产精品久久久| 国产区一区二久久| 午夜福利成人在线免费观看| 可以在线观看毛片的网站| 中文字幕精品免费在线观看视频| 欧美日韩精品网址| 国产精品综合久久久久久久免费 | 最近最新中文字幕大全免费视频| 亚洲人成电影观看| 久久久久久亚洲精品国产蜜桃av| 国产在线精品亚洲第一网站| 欧美一级a爱片免费观看看 | 这个男人来自地球电影免费观看| 精品国产一区二区久久| 最新美女视频免费是黄的| 高清在线国产一区| 一级毛片精品| 亚洲国产高清在线一区二区三 | 色哟哟哟哟哟哟| 男女做爰动态图高潮gif福利片 | √禁漫天堂资源中文www| 国产伦一二天堂av在线观看| 国产一区二区三区视频了| 午夜福利一区二区在线看| 亚洲av第一区精品v没综合| 精品一区二区三区四区五区乱码| 黄片播放在线免费| 亚洲专区国产一区二区| 精品一品国产午夜福利视频| 久久人妻熟女aⅴ| 一进一出抽搐动态| 欧美大码av| 亚洲精品av麻豆狂野| 精品久久久久久久人妻蜜臀av | 美女免费视频网站| 国产精品香港三级国产av潘金莲| 国产成年人精品一区二区| 少妇裸体淫交视频免费看高清 | 欧美一区二区精品小视频在线| 国产av在哪里看| 深夜精品福利| 一个人观看的视频www高清免费观看 | avwww免费| 亚洲国产高清在线一区二区三 | 这个男人来自地球电影免费观看| 国产麻豆69| 精品国内亚洲2022精品成人| 国产精品亚洲美女久久久| 少妇 在线观看| 亚洲精品在线观看二区| 1024香蕉在线观看| 一夜夜www| 亚洲人成电影免费在线| 欧洲精品卡2卡3卡4卡5卡区| 国产成人精品久久二区二区免费| 亚洲精品一卡2卡三卡4卡5卡| 嫩草影视91久久| 亚洲第一青青草原| 性色av乱码一区二区三区2| 欧美色欧美亚洲另类二区 | 高清黄色对白视频在线免费看| 亚洲精品国产色婷婷电影| 久久久久久人人人人人| 久久久久久久久久久久大奶| 看片在线看免费视频| 亚洲国产精品999在线| 这个男人来自地球电影免费观看| 国产亚洲精品一区二区www| 欧美黑人精品巨大| 真人一进一出gif抽搐免费| 91九色精品人成在线观看| 欧美黑人精品巨大| av片东京热男人的天堂| 97人妻天天添夜夜摸| 久久久水蜜桃国产精品网| 桃色一区二区三区在线观看| 身体一侧抽搐| 国产精品 国内视频| 精品一区二区三区av网在线观看| 美女午夜性视频免费| 青草久久国产| 欧美不卡视频在线免费观看 | 黄色女人牲交| 欧美乱妇无乱码| 高潮久久久久久久久久久不卡| 99国产精品一区二区三区| 大码成人一级视频| 50天的宝宝边吃奶边哭怎么回事| 欧美日韩精品网址| 99re在线观看精品视频| 国产亚洲精品久久久久5区| 亚洲成国产人片在线观看| 美国免费a级毛片| 18禁观看日本| 国产成人系列免费观看| 一个人免费在线观看的高清视频| 可以在线观看的亚洲视频| 国产精品一区二区在线不卡| 黑人操中国人逼视频| 亚洲精品中文字幕在线视频| 精品人妻在线不人妻| 又大又爽又粗| 亚洲天堂国产精品一区在线| 多毛熟女@视频| 真人一进一出gif抽搐免费| 精品午夜福利视频在线观看一区| 9191精品国产免费久久| www.自偷自拍.com| 亚洲成av片中文字幕在线观看| 桃红色精品国产亚洲av| 在线播放国产精品三级| 亚洲色图av天堂| 亚洲国产看品久久| 男女之事视频高清在线观看| 女人精品久久久久毛片| 久久精品亚洲精品国产色婷小说| 大型黄色视频在线免费观看| 在线天堂中文资源库| 午夜免费激情av| 好看av亚洲va欧美ⅴa在| 久久精品国产清高在天天线| 欧美日韩亚洲国产一区二区在线观看| 日韩欧美国产一区二区入口| 亚洲成av人片免费观看| 亚洲精品中文字幕在线视频| 男女下面插进去视频免费观看| 一级毛片女人18水好多| 日韩欧美一区二区三区在线观看| 首页视频小说图片口味搜索| 妹子高潮喷水视频| a级毛片在线看网站| 精品卡一卡二卡四卡免费| 亚洲激情在线av| 久久久久久亚洲精品国产蜜桃av| 男人舔女人的私密视频| 91国产中文字幕| 免费在线观看视频国产中文字幕亚洲| 亚洲中文av在线| 国产精品永久免费网站| 国产又爽黄色视频| 国产亚洲欧美98| 亚洲一区二区三区色噜噜| 两个人视频免费观看高清| 啦啦啦韩国在线观看视频| 日韩精品免费视频一区二区三区| 午夜老司机福利片| 少妇粗大呻吟视频| 中亚洲国语对白在线视频| 久久久久久久久中文| 亚洲成人国产一区在线观看| 日本在线视频免费播放| 久久国产精品男人的天堂亚洲| 久99久视频精品免费| av免费在线观看网站| 亚洲性夜色夜夜综合| 精品一区二区三区av网在线观看| 美女午夜性视频免费| 99久久国产精品久久久| 午夜视频精品福利| 国产亚洲av嫩草精品影院| 色播在线永久视频| 在线永久观看黄色视频| 亚洲欧美精品综合久久99| 亚洲成人久久性| 国产精品 国内视频| 国产熟女xx| 国产精品,欧美在线| 波多野结衣一区麻豆| 色精品久久人妻99蜜桃| 天天添夜夜摸| 黄色视频,在线免费观看| 美女 人体艺术 gogo| 国产成人精品久久二区二区免费| 国产三级在线视频| 母亲3免费完整高清在线观看| 日韩欧美国产在线观看| 亚洲成人久久性| 极品教师在线免费播放| 亚洲男人的天堂狠狠| 激情视频va一区二区三区| 91成年电影在线观看| 欧美成人免费av一区二区三区| 一级黄色大片毛片| 国产亚洲欧美在线一区二区| 精品欧美一区二区三区在线| 午夜两性在线视频| 淫秽高清视频在线观看| 成人亚洲精品av一区二区| 动漫黄色视频在线观看| or卡值多少钱| 日韩有码中文字幕| 国产亚洲精品综合一区在线观看 | 一进一出抽搐动态| 日本三级黄在线观看| 一区二区三区精品91| 黑人欧美特级aaaaaa片| 国产精品乱码一区二三区的特点 | 国产一区二区激情短视频| 很黄的视频免费| 色婷婷久久久亚洲欧美| 亚洲熟妇中文字幕五十中出| 久久伊人香网站| 精品国产亚洲在线| 大陆偷拍与自拍| 国产片内射在线| 国产亚洲精品第一综合不卡| 久久久久九九精品影院| 亚洲最大成人中文| 久久香蕉国产精品| 日本在线视频免费播放| 波多野结衣高清无吗| 十八禁人妻一区二区| 天天一区二区日本电影三级 | 成人18禁高潮啪啪吃奶动态图| 日韩免费av在线播放| 一边摸一边抽搐一进一小说| 亚洲精品av麻豆狂野| 亚洲国产毛片av蜜桃av| 两性夫妻黄色片| 免费无遮挡裸体视频| 亚洲男人天堂网一区| 老司机午夜福利在线观看视频| 一区二区三区激情视频| 中文字幕另类日韩欧美亚洲嫩草| 精品国产乱子伦一区二区三区| 亚洲成人精品中文字幕电影| 午夜亚洲福利在线播放| 一区二区三区国产精品乱码| 日本免费一区二区三区高清不卡 | 激情视频va一区二区三区| 精品免费久久久久久久清纯| 精品久久久久久久久久免费视频| 99re在线观看精品视频| 国产熟女午夜一区二区三区| 女人爽到高潮嗷嗷叫在线视频| 午夜福利一区二区在线看| 香蕉国产在线看| 国产成人免费无遮挡视频| 在线视频色国产色| 18禁裸乳无遮挡免费网站照片 | 色尼玛亚洲综合影院| 99久久久亚洲精品蜜臀av| 亚洲精品国产精品久久久不卡| 操美女的视频在线观看| 国产一级毛片七仙女欲春2 | av超薄肉色丝袜交足视频| 中文字幕av电影在线播放| 亚洲视频免费观看视频| 成人国语在线视频| 老熟妇仑乱视频hdxx| 男人的好看免费观看在线视频 | 后天国语完整版免费观看| 欧美精品亚洲一区二区| 国产一区二区在线av高清观看| 精品久久蜜臀av无| 又紧又爽又黄一区二区| 岛国视频午夜一区免费看| 成熟少妇高潮喷水视频| 老司机靠b影院| 久久天躁狠狠躁夜夜2o2o| 亚洲中文日韩欧美视频| 日本欧美视频一区| 禁无遮挡网站| 丝袜美足系列| 在线永久观看黄色视频| 成在线人永久免费视频| 久久久久久亚洲精品国产蜜桃av| 亚洲av五月六月丁香网| 黄色视频不卡| 久久草成人影院| 老汉色∧v一级毛片| 免费女性裸体啪啪无遮挡网站| 我的亚洲天堂| 免费少妇av软件| 久久草成人影院| 日本欧美视频一区| 多毛熟女@视频| av视频免费观看在线观看| svipshipincom国产片| 午夜福利一区二区在线看| 日本在线视频免费播放| 日韩欧美三级三区| 人妻丰满熟妇av一区二区三区| 亚洲av成人av| 日韩大尺度精品在线看网址 | 午夜日韩欧美国产| 黄色视频,在线免费观看| 91九色精品人成在线观看| 久久中文字幕一级| 久久精品亚洲熟妇少妇任你| 母亲3免费完整高清在线观看| 国产精品一区二区精品视频观看| 久久久久九九精品影院| 黄色 视频免费看| 在线观看免费午夜福利视频| 乱人伦中国视频| 国产亚洲欧美98| 在线视频色国产色| 欧洲精品卡2卡3卡4卡5卡区| 精品乱码久久久久久99久播| 亚洲色图综合在线观看| 亚洲性夜色夜夜综合| 又黄又粗又硬又大视频| 亚洲国产精品成人综合色| 777久久人妻少妇嫩草av网站| 色精品久久人妻99蜜桃| 999久久久精品免费观看国产| 久久久国产成人免费| 大型黄色视频在线免费观看| 在线av久久热| 亚洲成人精品中文字幕电影| av福利片在线| 亚洲专区国产一区二区| 久久久久久国产a免费观看| 97人妻精品一区二区三区麻豆 | 亚洲国产高清在线一区二区三 | 搡老妇女老女人老熟妇| 99久久国产精品久久久| 亚洲一区二区三区不卡视频| 18禁国产床啪视频网站| 97超级碰碰碰精品色视频在线观看| 夜夜看夜夜爽夜夜摸| 两个人视频免费观看高清| 精品卡一卡二卡四卡免费| www.999成人在线观看| 国产亚洲欧美精品永久| 中文字幕人成人乱码亚洲影| 高清在线国产一区| 天堂√8在线中文| 99国产精品99久久久久| 一夜夜www| 国产精品99久久99久久久不卡| 亚洲人成电影观看| 精品电影一区二区在线| 夜夜夜夜夜久久久久| 丁香欧美五月| 天堂影院成人在线观看| 欧美激情极品国产一区二区三区| 国产伦一二天堂av在线观看| 最近最新免费中文字幕在线| 亚洲成人久久性| 老司机午夜十八禁免费视频| av在线播放免费不卡| 日韩欧美国产在线观看| av中文乱码字幕在线| 国内精品久久久久久久电影| 国产真人三级小视频在线观看| 国产精品 欧美亚洲| 岛国视频午夜一区免费看| 国产1区2区3区精品| 精品国产乱码久久久久久男人| 日韩精品中文字幕看吧| a在线观看视频网站| 女人被躁到高潮嗷嗷叫费观| 女人被狂操c到高潮| 久久精品aⅴ一区二区三区四区| 久久国产精品人妻蜜桃| 色综合站精品国产| 女性被躁到高潮视频| 18禁裸乳无遮挡免费网站照片 | 久久国产乱子伦精品免费另类| 成熟少妇高潮喷水视频| 88av欧美| 色播在线永久视频| 国产精品久久久久久人妻精品电影| 亚洲欧美日韩另类电影网站| 女警被强在线播放| 久久国产精品男人的天堂亚洲| 级片在线观看| av有码第一页| 色婷婷久久久亚洲欧美| 给我免费播放毛片高清在线观看| 精品人妻1区二区| 亚洲精品国产一区二区精华液| 岛国视频午夜一区免费看| 精品高清国产在线一区| 日韩av在线大香蕉| 老汉色∧v一级毛片| 97超级碰碰碰精品色视频在线观看| 男人舔女人下体高潮全视频| 精品国产乱子伦一区二区三区| 亚洲性夜色夜夜综合| 午夜激情av网站| 制服诱惑二区| 午夜福利18| 正在播放国产对白刺激| 久久久久久大精品| 97人妻天天添夜夜摸| 好男人在线观看高清免费视频 | 一夜夜www| 亚洲熟女毛片儿| 国产成人一区二区三区免费视频网站| 精品国产一区二区三区四区第35| 久久人人爽av亚洲精品天堂| 嫩草影院精品99| 国产精品一区二区精品视频观看| 精品熟女少妇八av免费久了| 99re在线观看精品视频| 怎么达到女性高潮| 亚洲欧美一区二区三区黑人| 精品国产超薄肉色丝袜足j| 性少妇av在线| 精品国产美女av久久久久小说| 啦啦啦韩国在线观看视频| 国产伦人伦偷精品视频| 一区二区三区激情视频| 亚洲成a人片在线一区二区| 黄色女人牲交| 丝袜美足系列| 久久精品91无色码中文字幕| 午夜精品国产一区二区电影| 亚洲精品国产一区二区精华液| 一二三四社区在线视频社区8| 国产伦一二天堂av在线观看| 大香蕉久久成人网| 久久久国产欧美日韩av| 国产精品一区二区免费欧美| 欧美激情高清一区二区三区| 激情视频va一区二区三区| e午夜精品久久久久久久| 久久婷婷人人爽人人干人人爱 | 男女下面插进去视频免费观看| 999精品在线视频| 中文字幕色久视频| 亚洲久久久国产精品| 国产精品亚洲美女久久久| 国产成人影院久久av| 日本五十路高清| 亚洲第一电影网av| 亚洲狠狠婷婷综合久久图片| 久久国产精品影院| 很黄的视频免费| 丰满的人妻完整版| 国产亚洲精品av在线| 又大又爽又粗| 最好的美女福利视频网| xxx96com| 性色av乱码一区二区三区2| 国产99白浆流出| 久久草成人影院| 免费高清视频大片| 美女国产高潮福利片在线看| 日本一区二区免费在线视频| 两个人免费观看高清视频| 国产成人精品久久二区二区免费| 视频在线观看一区二区三区| 最好的美女福利视频网| 亚洲情色 制服丝袜| 免费女性裸体啪啪无遮挡网站| 国产一级毛片七仙女欲春2 | 老熟妇乱子伦视频在线观看| 18禁黄网站禁片午夜丰满| 日韩欧美一区视频在线观看| 午夜日韩欧美国产| 亚洲精华国产精华精| 波多野结衣高清无吗| 级片在线观看| 91av网站免费观看| 色哟哟哟哟哟哟| 色av中文字幕| 亚洲av日韩精品久久久久久密| 亚洲专区国产一区二区| 日本撒尿小便嘘嘘汇集6| 欧美午夜高清在线| 国产成+人综合+亚洲专区| 制服诱惑二区| 亚洲国产看品久久| 男男h啪啪无遮挡| av超薄肉色丝袜交足视频| 波多野结衣高清无吗| 欧美大码av| 日本免费a在线| 老司机靠b影院| www.精华液| 精品久久久久久久毛片微露脸| 欧美成人午夜精品| 中文字幕色久视频| 亚洲精品国产精品久久久不卡| 国产精品1区2区在线观看.| 日韩一卡2卡3卡4卡2021年| 欧美黄色片欧美黄色片| 在线十欧美十亚洲十日本专区| av福利片在线| 免费av毛片视频| 亚洲午夜理论影院| 高清毛片免费观看视频网站| 亚洲成人精品中文字幕电影| 啦啦啦韩国在线观看视频| 日本 欧美在线| 国产三级在线视频| 中文字幕久久专区| 最近最新免费中文字幕在线| 国产三级在线视频| 精品国内亚洲2022精品成人| 国产精品 国内视频| 男女午夜视频在线观看| 日韩大尺度精品在线看网址 | 久久久久久人人人人人| 国产片内射在线| 久久人妻熟女aⅴ| 精品电影一区二区在线| av天堂久久9| 51午夜福利影视在线观看| 亚洲全国av大片| 91大片在线观看| 高清黄色对白视频在线免费看| www.自偷自拍.com| 国产在线精品亚洲第一网站| 亚洲国产精品成人综合色| 亚洲精品一区av在线观看| 免费观看精品视频网站| 18美女黄网站色大片免费观看| 亚洲自拍偷在线| 久久国产亚洲av麻豆专区| 午夜福利视频1000在线观看 | 啦啦啦韩国在线观看视频| 免费看十八禁软件|